Shan Jiang

China Pharmaceutical University — China

Neuroscience · Life Sciences

12h-index3.1kcitations38works27.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroinflammation and Neurodegeneration Mechanisms(12), Tryptophan and brain disorders(12), Long-Term Effects of COVID-19(7), Genetic Associations and Epidemiology(5), Genomic variations and chromosomal abnormalities(5)

Publications37 total

A Novel Risk Prediction Model for Post-treatment Ischemic Stroke Recurrence Using Plasma Antithrombin III and Thromboelastography
Journal of Medical Biochemistry·2025Open Access
Nanomicelle with reversible surface properties as a general adjuvant for potentiating immune responses to multiple types of tumor antigens
Journal of Controlled Release·2025· 2 cited
Mining minor cold-resistant genes in V. vinifera based on transcriptomics
2024Open Access
Single-cell multi-cohort dissection of the schizophrenia transcriptome
Science·2024· 108 citedOpen Access
FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells
Nature Communications·2023· 28 citedOpen Access
Population-level variation in enhancer expression identifies disease mechanisms in the human brain
Nature Genetics·2022· 49 citedOpen Access
A translational genomics approach identifies IL10RB as the top candidate gene target for COVID-19 susceptibility
npj Genomic Medicine·2022· 17 citedOpen Access
Single-cell multi-cohort dissection of the schizophrenia transcriptome
2022· 29 citedOpen Access
Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Genome Medicine·2021· 114 citedOpen Access
Genome-Wide Correlation of DNA Methylation and Gene Expression in Postmortem Brain Tissues of Opioid Use Disorder Patients
The International Journal of Neuropsychopharmacology·2021· 39 citedOpen Access
IL10RB as a key regulator of COVID-19 host susceptibility and severity
2021· 14 citedOpen Access
The landscape of human brain immune response in patients with severe COVID-19
2021· 1 citedOpen Access
Additional file 4 of Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Figshare·2021Open Access
Additional file 7 of Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Figshare·2021Open Access
Additional file 10 of Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Figshare·2021Open Access
Additional file 3 of Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Figshare·2021Open Access
Additional file 9 of Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Figshare·2021Open Access
Additional file 5 of Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Figshare·2021Open Access
Additional file 6 of Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Figshare·2021Open Access
Additional file 1 of Single-nucleus transcriptome analysis of human brain immune response in patients with severe COVID-19
Figshare·2021Open Access
page 1 of 2Next →

Frequent Co-authors

John F. Fullard(16), Georgios Voloudakis(16), Gabriel E. Hoffman(16), Panos Roussos(16), Schahram Akbarian(15), Hao-Chih Lee(13), André Corvelo(13), Shengbao Suo(11), Behnam Javidfar(11), Zhiping Shao(11), Cyril Peter(11), Emma Woodoff‐Leith(11), Dushyant P. Purohit(11), Mary Fowkes(11), John F. Crary(11), Guo‐Cheng Yuan(11), Heather Wargnier(10), Sadhna Ahuja(10), Nadejda M. Tsankova(10), Nathalie Jetté(10)